Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | RARA | P10276 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | LDHB | P07195 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.43 |
| ▸ | BID | P55957 | 1/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29670029 | 0.90 | RARB (0.50) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL290671 | 0.90 | RARB (0.50) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL168254 | 0.83 | BID (0.48) | ALDH1A1MAPTBIDBCL2L1MCL1 | |
| SCHEMBL29138979 | 0.78 | BID (0.54) | ALDH1A1MAPTBIDBCL2L1MCL1 | |
| SCHEMBL11094349 | 0.76 | ALDH1A1 (0.53) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL18543774 | 0.75 | RARB (0.49) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL28496833 | 0.75 | RARB (0.49) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL1615392 | 0.73 | BID (0.49) | ALDH1A1MAPTBIDBCL2L1MCL1 | |
| SCHEMBL7944628 | 0.73 | BID (0.46) | RARBMEN1ALDH1A1RARAMAPT | |
| SCHEMBL18481326 | 0.73 | OXER1 (0.44) | ALDH1A1LDHALDHBBIDBCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2193785-B1 | Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes | SYMRISE AG (DE) | 2018-07-18 | — | — | EP | disclosed |
| US-9445988-B2 | Extracts of Tetraselmis sp | SYMRISE AG (DE) | 2016-09-20 | — | — | US | disclosed |
| EP-2168570-B1 | Extracts of isochrysis sp. | SYMRISE AG (DE) | 2013-12-25 | — | — | EP | disclosed |
| EP-1954831-B1 | AHR MEDIATOR | SYMRISE AG (DE) | 2012-07-11 | — | — | EP | disclosed |
| US-20100143267-A1 | EXTRACTS OF TETRASELMIS SP. | SYMRISE GMBH & CO. KG (DE) | 2010-06-10 | — | — | US | disclosed |
| EP-2193785-A2 | Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes | Symrise GmbH & Co. KG (DE) | 2010-06-09 | — | — | EP | disclosed |
| EP-2168570-A2 | Extracts of isochrysis sp. | Symrise GmbH & Co. KG (DE) | 2010-03-31 | — | — | EP | disclosed |
| US-20080305054-A1 | Use of Glycosylated Flavanones for the Browning of Skin or Hair | SYMRISE GMBH & CO. KG (DE) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305054-A1 | Use of Glycosylated Flavanones for the Browning of Skin or Hair | FUT6, FUT5, DPM1 | RARB 1481/4885MEN1 2135/4885ALDH1A1 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.